Clari Vest Asset Management LLC Vaxcyte, Inc. Transaction History
Clari Vest Asset Management LLC
- $1 Billion
- Q3 2024
A detailed history of Clari Vest Asset Management LLC transactions in Vaxcyte, Inc. stock. As of the latest transaction made, Clari Vest Asset Management LLC holds 4,140 shares of PCVX stock, worth $325,611. This represents 0.05% of its overall portfolio holdings.
Number of Shares
4,140
Previous 4,140
-0.0%
Holding current value
$325,611
Previous $312,000
51.28%
% of portfolio
0.05%
Previous 0.03%
Shares
2 transactions
Others Institutions Holding PCVX
# of Institutions
349Shares Held
130MCall Options Held
539KPut Options Held
253K-
Vanguard Group Inc Valley Forge, PA12MShares$941 Million0.02% of portfolio
-
Janus Henderson Group PLC London, X010.6MShares$832 Million0.46% of portfolio
-
Black Rock Inc. New York, NY9.94MShares$782 Million0.02% of portfolio
-
Ra Capital Management, L.P. Boston, MA8.69MShares$683 Million11.52% of portfolio
-
Capital Research Global Investors Los Angeles, CA6.21MShares$488 Million0.11% of portfolio
About Vaxcyte, Inc.
- Ticker PCVX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,315,100
- Market Cap $4.67B
- Description
- Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...